Search for Clinical Trials
A Prospective, Multi-Center, Randomized, Double-Arm Trial To Determine The Impact Of The SELENE System On Positive Margin Rates In Breast…
Introduction: Comorbidities pose significant challenges to the delivery of quality cancer treatment. Medically underserved patients have the highest…
This study is a first in human Phase 1 study that involves patients with a type of cancer called HER2 (Human Epidermal Growth Factor Receptor 2)…
The main purpose of this study is to look at the safety and effectiveness of the standard anti-HER2-targeted therapies.
This study is being done to learn more about the safety and effectiveness of an investigational oral medication called ORIN1001 for people with…
A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone.
Tucatinib is a type of drug…
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
A study to determine if the addition of atezolizumab to chemotherapy improves response in the breast and lymph nodes in patients with triple-negative…
